Characteristics (No. of patients) | SIRPαhi | SIRPαlow | P-value |
---|---|---|---|
Gender | |||
Male | 26 | 21 | |
Female | 16 | 18 | 0.463 |
Age (years) | |||
≥ 60 | 17 | 21 | |
< 60 | 25 | 18 | 0.228 |
ECOG PS | |||
0 | 19 | 18 | |
1 | 23 | 21 | 0.934 |
Size of primary tumor(cm) | |||
≥ 5 | 3 | 4 | |
< 5 | 39 | 35 | 0.618 |
Histopathological grading | |||
Low | 20 | 17 | |
Intermediate to high | 22 | 22 | 0.716 |
TNM stage | |||
I + II | 22 | 32 | |
III | 20 | 7 | 0.005 |
Lymph node invasion | |||
Yes | 14 | 2 | |
No | 28 | 37 | 0.001 |
Microvascular invasion | |||
Yes | 15 | 2 | |
No | 27 | 37 | 0.001 |
HBV | |||
Yes | 17 | 3 | |
No | 25 | 36 | 0.001 |
HCV | |||
Yes | 1 | 1 | |
No | 41 | 38 | 0.958 |
Liver cirrhosis | |||
Yes | 4 | 6 | |
No | 38 | 33 | 0.423 |
Child–Pugh grade | |||
A | 2 | 12 | |
B | 40 | 27 | 0.002 |
CEA (ng/mL) | |||
≥ 10 | 4 | 3 | |
< 10 | 38 | 36 | 0.769 |
CA199(U/mL) | |||
≥ 60 | 30 | 32 | |
< 60 | 12 | 7 | 0.26 |
CA724(U/mL) | |||
≥ 14 | 30 | 25 | |
< 14 | 12 | 14 | 0.48 |
ALT(U/L) | |||
≥ 80 | 31 | 25 | |
< 80 | 11 | 14 | 0.345 |
AST(U/L) | |||
≥ 70 | 26 | 24 | |
< 70 | 16 | 15 | 0.75 |
Total bilirubin (umol/L) | |||
≥ 42 | 36 | 33 | |
< 42 | 6 | 6 | 0.889 |
Direct bilirubin (umol/L) | |||
≥ 16 | 38 | 34 | |
< 16 | 4 | 5 | 0.637 |
Indirect bilirubin (umol/L) | |||
≥ 30 | 28 | 21 | |
< 30 | 14 | 18 | 0.238 |